Italia markets closed

BMY Jun 2024 46.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,8600+0,0400 (+4,88%)
Alla chiusura: 03:37PM EDT
Schermo intero
Chiusura precedente0,8200
Aperto0,8600
Denaro0,8800
Lettera0,9200
Prezzo d'esercizio46,00
Scadenza2024-06-21
Min-Max giorno0,7800 - 0,8700
Contratto - Min-MaxN/D
Volume381
Open Interest2,9k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri